Dr . Kausik Paul | Immunology and Microbiology | Best Researcher Award

Project Scientist at Cedars-Sinai Medical Center , United States

Dr. Kausik Paul is a dedicated immunologist and project scientist at Cedars-Sinai Medical Center, specializing in red blood cell (RBC) alloimmunization and transfusion medicine. With a strong academic foundation in microbiology, biophysics, and immunology, he has contributed significantly to understanding immune responses in lupus and transfusion settings. His work includes notable first-author publications in Frontiers in Immunology and Antioxidants, as well as multiple conference presentations on alloantibody responses in lupus mouse models. Dr. Paul has a strong history of scientific productivity, including peer-reviewed publications, patents, and impactful collaborative research. His technical expertise spans flow cytometry, cytokine profiling, and qPCR, supporting his efforts to refine personalized transfusion protocols. While he could further enhance his profile by securing independent funding and leading larger-scale projects, his current contributions reflect originality, depth, and clinical relevance. Dr. Paul is a highly suitable candidate for the Best Researcher Award, with clear potential for continued impactful research.

Professional Profile 

• Google Scholar

Education🎓

Dr. Kausik Paul has a comprehensive and interdisciplinary educational background that has shaped his expertise in immunology and transfusion medicine. He began his academic journey with a Bachelor of Science in Microbiology, followed by a Master’s degree in Biophysics from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad. His growing interest in immune mechanisms led him to pursue a Ph.D. in Infectious Diseases and Immunology at IICB-CSIR and Jadavpur University, Kolkata, where he developed a strong foundation in antigen-antibody interactions and immune response regulation. To further expand his knowledge, Dr. Paul completed postdoctoral training in immunology at the University of Manitoba and the University of Arizona, gaining exposure to advanced immunological techniques and research models. His education has been integral to his development as a researcher, equipping him with the scientific rigor and technical skills necessary to investigate complex immune responses, particularly in the context of RBC alloimmunization and autoimmune conditions like lupus.

Professional Experience📝

Dr. Kausik Paul has amassed extensive professional experience in immunology, with a focus on transfusion medicine and red blood cell (RBC) alloimmunization. Currently serving as a Project Scientist at Cedars-Sinai Medical Center since 2022, he leads research exploring immune responses to RBC antigens, particularly in lupus models. Prior to this, he held faculty positions as an Assistant Professor at Seacom Skills University and Glocal University, where he was involved in both teaching and research. His earlier postdoctoral appointments at the University of Manitoba and the University of Arizona enriched his expertise in cellular immunology and advanced laboratory techniques. Throughout his career, Dr. Paul has demonstrated a strong command of experimental approaches such as flow cytometry, cytokine profiling, and qPCR. His roles have included both independent and collaborative research, manuscript writing, and conference presentations. These experiences have collectively positioned him as a skilled and impactful researcher in the field of immunological science.

Research Interest🔎

Dr. Kausik Paul’s research interests lie primarily in immunology, with a specialized focus on red blood cell (RBC) alloimmunization, autoimmune disorders, and transfusion medicine. He is particularly interested in understanding the molecular and cellular mechanisms behind alloantibody formation in response to RBC antigens, especially in autoimmune conditions such as lupus. His current research explores the roles of type 1 and type 2 interferons in modulating immune responses to transfused RBCs, aiming to develop personalized transfusion strategies that minimize alloimmunization risk. Dr. Paul is also deeply invested in investigating inflammatory cytokine profiles, interferon-stimulated gene expression, and antigen presentation processes. His long-term goal is to translate basic immunological findings into clinically applicable solutions that enhance patient outcomes during blood transfusion therapies. Through the integration of advanced immunological techniques and animal models, Dr. Paul aspires to contribute significantly to the field of transfusion science and improve therapeutic protocols for immunocompromised

Award and Honor🏆

Dr. Kausik Paul has been recognized with several prestigious awards and honors throughout his academic and research career, reflecting his dedication and contributions to the field of immunology. He was the recipient of the Senior Research Fellowship (SRF) from the Council of Scientific and Industrial Research (CSIR), India, in 2007, which is awarded to outstanding doctoral candidates in scientific research. In 2006, he was also granted a Senior Research Fellowship through a project funded by the Department of Biotechnology (DBT), India, underscoring his involvement in high-impact research initiatives. Earlier, in 2003, Dr. Paul received a Research Fellowship under a project funded by the Department of Science and Technology (DST), India, during the initial stages of his research career. These honors not only highlight his scientific capabilities but also demonstrate the recognition he has earned from national funding agencies for his commitment to advancing biomedical research and innovation in immunology and related fields.

Research Skill🔬

Dr. Kausik Paul possesses a comprehensive range of research skills that span basic and translational immunology, with a strong emphasis on red blood cell (RBC) alloimmunization and autoimmune disease models. He is highly proficient in advanced laboratory techniques, including flow cytometry for cellular analysis and crossmatching, quantitative PCR for gene expression profiling, and ELISA-based assays for measuring cytokines and immune responses. His expertise extends to in vivo experimental design using mouse models, particularly in lupus research, where he investigates type 1 and type 2 interferon pathways and their influence on alloantibody production. Dr. Paul also demonstrates strong analytical skills in data interpretation, experimental troubleshooting, and scientific writing, as evidenced by his numerous publications and conference presentations. His ability to integrate immunological theory with practical experimentation has been instrumental in uncovering novel insights into transfusion medicine. Collectively, his technical competencies and critical thinking make him a valuable contributor to biomedical research.

Conclusion💡

Dr. Kausik Paul demonstrates a strong case for the Best Researcher Award, especially within the domains of transfusion medicine and immunology. He has a proven track record of impactful research, interdisciplinary collaboration, innovation (patents), and consistent engagement with the global scientific community through publications and conferences.

While there are areas he can build on—especially independent funding, mentorship, and institutional leadership—his current trajectory and recent accomplishments, particularly in a high-impact field like lupus-related RBC alloimmunization, are highly commendable.

Publications Top Noted✍

• Title: Activated T lymphocytes migrate toward the cathode of DC electric fields in microfluidic devices
  Authors: J Li, S Nandagopal, D Wu, SF Romanuik, K Paul, DJ Thomson, F Lin
  Year: 2011
  Citations: 91

• Title: N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl⁺ cells by endothelial nitric oxide synthase-mediated production of nitric oxide
  Authors: S Rakshit, J Bagchi, L Mandal, K Paul, D Ganguly, S Bhattacharjee, …
  Year: 2009
  Citations: 48

• Title: Leishmania donovani Infection of Human Myeloid Dendritic Cells Leads to a Th1 Response in CD4⁺ T Cells from Healthy Donors and Patients with Kala-Azar
  Authors: M Ghosh, L Mandal, S Maitra, S Rakshit, K Paul, J Bagchi, D Ganguly, …
  Year: 2006
  Citations: 30

• Title: Granulocyte–macrophage colony‐stimulating factor drives monocytes to CD14^low CD83⁺ DCSIGN⁻ interleukin‐10‐producing myeloid cells with differential …
  Authors: D Ganguly, K Paul, J Bagchi, S Rakshit, L Mandal, G Bandyopadhyay, …
  Year: 2007
  Citations: 26

• Title: Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis
  Authors: S Mallick, S Halder, A Dutta, S Dey, K Paul, S Maiti, C Bandyopadhyay, …
  Year: 2013
  Citations: 22

• Title: Dendritic cells and antigen trapping technology—a revolution in vaccine/immunotherapy strategy
  Authors: C Pal, D Ganguly, K Paul, S Pal
  Year: 2007
  Citations: 5

• Title: Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models
  Authors: K Paul, R Hernández-Armengol, JY Lee, CY Chang, T Shibata, …
  Year: 2024
  Citations: 3

• Title: Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)
  Authors: S Bandyopadhyay, BC Pal, J Parasuraman, S Roy, JB Chakrabotry, …
  Year: 2016
  Citations: 1

• Title: Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent …
  Authors: JB Chakraborty, SK Mahato, K Joshi, V Shinde, S Rakshit, N Biswas, …
  Year: 2012
  Citations: 1